Konica Minolta Inc. and Innovation Network Corporation of Japan, a public-private investment company that invests in innovative businesses, will pay $800m for Aliso Viejo, Calif.-based Ambry Genetics, with another $200m due Ambry shareholders pending the achievement of certain metrics over the next two years, the companies announced July 6.
Konica Minolta will invest 60% and INCJ will account for the remaining 40%, making Ambry part of Konica Minolta Healthcare...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?